Effects of different hypoxia exposure on myeloid-derived suppressor cells in mice
For many people living at high altitudes for long or short periods of time, hypoxia is a challenge affecting many aspects of the body, including the immune system. Recently, myeloid-derived suppressor cells (MDSCs) have emerged as an immune cell population that plays an important role in several pat...
| Published in: | Experimental and Molecular Pathology |
|---|---|
| Main Authors: | Qiying Xu, Huifang Liu, Yi Ye, Tana Wuren, Ri-li Ge |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0014480024000510 |
Similar Items
Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)
by: AV Ponomarev
Published: (2017-01-01)
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice
by: Fangzhen Shan, et al.
Published: (2024-02-01)
by: Fangzhen Shan, et al.
Published: (2024-02-01)
Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)
Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01)
by: Jisu Kim, et al.
Published: (2023-03-01)
Myeloid-derived suppressor cells in gliomas
by: Anna Gieryng, et al.
Published: (2016-12-01)
by: Anna Gieryng, et al.
Published: (2016-12-01)
The Yin and Yang of Myeloid Derived Suppressor Cells
by: Snehil Budhwar, et al.
Published: (2018-11-01)
by: Snehil Budhwar, et al.
Published: (2018-11-01)
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
by: Shunjie Yu, et al.
Published: (2022-07-01)
by: Shunjie Yu, et al.
Published: (2022-07-01)
Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
by: Shin Young Hyun, et al.
Published: (2020-10-01)
by: Shin Young Hyun, et al.
Published: (2020-10-01)
Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)
by: Emma Keltsch, et al.
Published: (2025-07-01)
The clinical significance of myeloid-derived suppressor cells in dengue fever patients
by: Peng-Le Guo, et al.
Published: (2019-11-01)
by: Peng-Le Guo, et al.
Published: (2019-11-01)
Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)
by: Udovičić Ivo, et al.
Published: (2020-01-01)
Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness is Associated with Favorable Clinical Outcomes
by: Jia L, et al.
Published: (2025-05-01)
by: Jia L, et al.
Published: (2025-05-01)
Astaxanthin Treatment Induces Maturation and Functional Change of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
by: Seong Mun Jeong, et al.
Published: (2020-04-01)
by: Seong Mun Jeong, et al.
Published: (2020-04-01)
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)
by: Chengyuan Li, et al.
Published: (2025-02-01)
Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
by: Xiyang Ren, et al.
Published: (2022-11-01)
by: Xiyang Ren, et al.
Published: (2022-11-01)
The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)
by: Jordan Brauner, et al.
Published: (2025-02-01)
Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)
by: Tianmiao Ma, et al.
Published: (2022-01-01)
Cytokine-Induced Myeloid-Derived Suppressor Cells Demonstrate Their Immunoregulatory Functions to Prolong the Survival of Diabetic Mice
by: Tung-Teng Li, et al.
Published: (2023-05-01)
by: Tung-Teng Li, et al.
Published: (2023-05-01)
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
by: Mohammad A. Al-Mterin, et al.
Published: (2022-08-01)
by: Mohammad A. Al-Mterin, et al.
Published: (2022-08-01)
Myeloid-derived suppressor cells and pulmonary hypertension
by: Hui Zhang, et al.
Published: (2023-06-01)
by: Hui Zhang, et al.
Published: (2023-06-01)
Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells
by: Oliver Goldmann, et al.
Published: (2024-10-01)
by: Oliver Goldmann, et al.
Published: (2024-10-01)
Myeloid-derived suppressor cells in influenza virus-induced asthma exacerbation
by: Chiel van Geffen, et al.
Published: (2024-04-01)
by: Chiel van Geffen, et al.
Published: (2024-04-01)
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
by: Vaishali Bhardwaj, et al.
Published: (2023-04-01)
by: Vaishali Bhardwaj, et al.
Published: (2023-04-01)
IRF4 regulates myeloid-derived suppressor cells expansion and function in Schistosoma japonicum-infected mice
by: Lu Zhou, et al.
Published: (2024-11-01)
by: Lu Zhou, et al.
Published: (2024-11-01)
Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis
by: Juanjuan Cui, et al.
Published: (2024-04-01)
by: Juanjuan Cui, et al.
Published: (2024-04-01)
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
by: Juan F. Santibanez
Published: (2025-03-01)
by: Juan F. Santibanez
Published: (2025-03-01)
The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)
Role of myeloid-derived suppressor cells in hormone-dependent cancers
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)
Functional characterization of human Cd33<sup>+ </sup>And Cd11b<sup>+ </sup>myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
by: Arger Nicholas, et al.
Published: (2011-06-01)
by: Arger Nicholas, et al.
Published: (2011-06-01)
The role of myeloid derived suppressor cells in musculoskeletal disorders
by: Yi Ren, et al.
Published: (2023-03-01)
by: Yi Ren, et al.
Published: (2023-03-01)
Molecular mechanisms governing the differentiation and expansion of myeloid-derived suppressor cells
by: Ke Wang, et al.
Published: (2025-10-01)
by: Ke Wang, et al.
Published: (2025-10-01)
Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
by: Haomin Yan, et al.
Published: (2023-03-01)
by: Haomin Yan, et al.
Published: (2023-03-01)
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
by: Xidan Gao, et al.
Published: (2021-02-01)
by: Xidan Gao, et al.
Published: (2021-02-01)
Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review
by: Beatriz Pérez-Peláez, et al.
Published: (2024-08-01)
by: Beatriz Pérez-Peláez, et al.
Published: (2024-08-01)
Candida-induced granulocytic myeloid-derived suppressor cells are protective against polymicrobial sepsis
by: Shannon Esher Righi, et al.
Published: (2023-10-01)
by: Shannon Esher Righi, et al.
Published: (2023-10-01)
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
by: Junli Lu, et al.
Published: (2024-04-01)
by: Junli Lu, et al.
Published: (2024-04-01)
Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)
by: Clément Klein, et al.
Published: (2024-10-01)
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)
by: Andrew M. K. Law, et al.
Published: (2020-02-01)
Evaluation of the clinical significance of lymphocyte subsets and myeloid suppressor cells in patients with renal carcinoma
by: Yan Li, et al.
Published: (2024-09-01)
by: Yan Li, et al.
Published: (2024-09-01)
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
by: Karolina Okła
Published: (2023-07-01)
by: Karolina Okła
Published: (2023-07-01)
Similar Items
-
Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01) -
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice
by: Fangzhen Shan, et al.
Published: (2024-02-01) -
Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01) -
Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01) -
Myeloid-derived suppressor cells in gliomas
by: Anna Gieryng, et al.
Published: (2016-12-01)
